Emergent patents expiration
1. Narcan patents expiration
NARCAN Litigations
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9629965 | EMERGENT | Nasal drug products and methods of their use |
Mar, 2035
(10 years from now) | |
| US9480644 | EMERGENT | Nasal drug products and methods of their use |
Mar, 2035
(10 years from now) | |
| US10085937 | EMERGENT | Nasal drug products and methods of their use |
Mar, 2035
(10 years from now) | |
| US9707226 | EMERGENT | Nasal drug products and methods of their use |
Mar, 2035
(10 years from now) | |
| US9561177 | EMERGENT | Nasal drug products and methods of their use |
Mar, 2035
(10 years from now) | |
| US9468747 | EMERGENT | Nasal drug products and methods of their use |
Mar, 2035
(10 years from now) | |
| US9211253 | EMERGENT | Nasal drug products and methods of their use |
Mar, 2035
(10 years from now) | |
| US9775838 | EMERGENT | Nasal drug products and methods of their use |
Mar, 2035
(10 years from now) | |
Drugs and Companies using NALOXONE HYDROCHLORIDE ingredient
Market Authorisation Date: 24 January, 2017
Treatment: Use of naloxone hydrochloride for emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression.
Dosage: SPRAY, METERED;NASAL
How can I launch a generic of NARCAN before it's drug patent expiration?
More Information on Dosage
NARCAN family patents
